✦ LIBER ✦

The AFFIRM Trial: Main Trial and Substudies—What Can We Expect?

✍ Scribed by D. George Wyse

Book ID: 110281511
Publisher: Springer
Year: 2000
Tongue: English
Weight: 98 KB
Volume: 4
Category: Article
ISSN: 1383-875X
DOI: 10.1023/a:1009815606734

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical aspects of trial design: What c

Clinical aspects of trial design: What can we expect from the cardiac arrhythmia suppression trial?

✍ J. Thomas Bigger 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 782 KB

What kind of research can we realistical

What kind of research can we realistically expect from the practitioner?

✍ Georgios K. Lampropoulos; Marvin R. Goldfried; Louis G. Castonguay; Michael J. L 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

## Abstract This article attempts to revitalize the scientist‐practitioner model of psychotherapy by focusing on the research component of the model. Specifically, it takes a realistic look at the types of research that can be conducted by clinicians in an effort to motivate them to engage regularl

Rare diseases and the assessment of inte

Rare diseases and the assessment of intervention: What sorts of clinical trials can we use?

✍ B. Wilcken 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 106 KB

What Can We Expect from Mesoporous Mater

What Can We Expect from Mesoporous Materials in the Field of Heterogeneous Catalysis?

✍ Masakazu Iwamoto 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 51 KB

Alternatives to current disease-modifyin

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

✍ Ludwig Kappos; Jens Kuhle; Achim Gass; Lutz Achtnichts; Ernst-Wilhelm Radue 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 300 KB

Prostate Cancer Screening: What We Have

Prostate Cancer Screening: What We Have Learned from the PLCO and ERSPC Trials

✍ Jeffrey La Rochelle; Christopher L. Amling 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 93 KB